Accelerate Your Drug Development with QPS Real-World Evidence (RWE) Services
Harnessing Real-World Data for Innovative Insights
Our Capabilities
Data Integration and Harmonization
We integrate electronic health records (EHRs), pathology results, registries, and genomic data into a centralized data lake environment enhanced by AI and machine learning for deeper clinical insights. This integration allows for a comprehensive view of patient health, enabling more accurate and personalized treatment strategies. By harmonizing diverse data sources, we ensure consistency and reliability in our analyses, providing a solid foundation for evidence generation.
Research-Ready Datasets
We develop customized datasets tailored to specific therapeutic areas, enabling more targeted analysis and improved decision-making. Our datasets are meticulously curated to include relevant patient information, clinical outcomes, and treatment histories. This targeted approach allows researchers to focus on specific questions and hypotheses, leading to more meaningful and actionable insights. Whether it’s oncology, CNS disorders, or rare diseases, our datasets are designed to support the unique needs of each therapeutic area.
Real-Time Data Collection and Longitudinal Tracking
We collect data in real time while maintaining strict adherence to global regulatory standards, including 21 CFR Part 11 and GDPR, to ensure data privacy, security, and compliance. Our real-time data collection capabilities allow for continuous monitoring of patient health and treatment outcomes, providing up-to-date information for timely decision-making. Longitudinal tracking ensures that we capture the full spectrum of patient experiences over time, offering insights into long-term efficacy and safety of therapies.
Streamlined Analysis and Reporting
We deliver structured data analysis, comprehensive reporting, and regulatory-ready documentation to accelerate submissions and approvals. Our analytical tools and methodologies are designed to extract meaningful insights from complex datasets, providing clear and concise reports that meet regulatory requirements. We offer end-to-end support for data analysis, from initial data processing to final report generation, ensuring that our clients have the information they need to make informed decisions and achieve regulatory success.
Why Choose QPS?
- Global Reach and Infrastructure: Our global infrastructure includes clinical research units and over 700 partner sites across the US, Europe, Asia, Australia, and India, allowing us to provide comprehensive support at every stage of the product lifecycle.
- Expertise Across Therapeutic Areas: Our therapeutic agnosticism allows for data-driven strategies across a diverse range of indications, including oncology, CNS disorders, dermatology, vaccines, and rare diseases.
- Multidisciplinary Team: Our client-first model is underpinned by a multidisciplinary team of data scientists, biostatisticians, medical writers, and pharmacovigilance experts, all working seamlessly under one umbrella to deliver comprehensive project support.
- Lifecycle Support: From early-stage research to post-marketing surveillance and label expansions, QPS assembles the right data, analytical tools, and expertise to meet evolving project demands effectively.
Contact Us
Ready to accelerate your drug development with QPS RWE services?
Contact us today to discuss how we can help you apply RWD/RWE integration for more efficient product development.
Visit: http://www.qps.com/
Set Up a Meeting: http://www.qps.com/contact
Email: info@qps.com
